Eli Lilly’s late-stage trial of its leading monoclonal antibody treatment for the coronavirus has been paused by U.S. health regulators over potential safety concerns, the company confirmed to CNBC on Tuesday.
U.S. pauses Eli Lilly’s trial of a coronavirus antibody treatment
Recent Comments